Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€108.55

€108.55

1.300%
1.4
1.300%
€129.84

€129.84

 
16.03.26 / Tradegate WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Stock / ? /
Latest predictions
16.03.26
0.00%
buy
€148.47
25.02.26
-4.45%
buy
€135.74
25.02.26
-4.70%
buy
€147.62
25.02.26
-11.46%
buy
28.12.25
2.31%
buy
22.12.25
-3.85%
buy
Best running prediction
€92.19
29.04.25
35.93%
buy
Your prediction

Transmedics Group Inc Stock

There is an upward development for Transmedics Group Inc compared to yesterday, with an increase of €1.40 (1.300%).
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Transmedics Group Inc.
With a target price of 129 € there is a slightly positive potential of 18.84% for Transmedics Group Inc compared to the current price of 108.55 €.
So far the community has only identified positive things for Transmedics Group Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Transmedics Group Inc in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

TransMedics Group (TMDX) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -4.45%
Target price 148.470
Change
Ends at 25.02.27

TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -4.70%
Target price 135.744
Change
Ends at 25.02.27

TransMedics Group (TMDX) had its price target raised by Piper Sandler from $140.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more